Brad Shapiro

Brad Shapiro, MD, is a Professor of Psychiatry at the University of California, San Francisco (UCSF) School of Medicine. His research focuses on substance use disorders, particularly opioid addiction treatment, healthcare access for marginalized populations, and reproductive health for patients with co-occurring substance use and homelessness. He has authored over 30 peer-reviewed publications, including studies on methadone treatment protocols, mobile healthcare innovations for opioid use disorder, and barriers to reproductive care for homeless women.

• Education & Training: Completed Diversity, Equity, and Inclusion Champion Training at UCSF (2017-2018).
• Key Research Areas:
  • Optimizing methadone treatment strategies in perinatal and fentanyl-exposed populations
  • Healthcare accessibility for homeless individuals with substance use disorders
  • Reducing stigma in neonatal care and reproductive health communication
• Recent Work Trends: Publications emphasize interdisciplinary solutions (e.g., methadone vans), policy-relevant findings on housing instability and abortion outcomes, and innovative clinical trial designs for addiction therapies.
• Grants & Collaborations: Active collaborations with UCSF colleagues including Dr. Scott Steiger, Dr. Leslie Suen, and Dr. Dominika Seidman. Research supported by grants focusing on urban health equity and addiction medicine.
• Labs/Teams: Works within UCSF's Department of Psychiatry addiction medicine research group, contributing to national discussions on opioid epidemic interventions.